A. V. Gasparian

9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-κB and p53 pathways

Chuanbin Guo, A. V. Gasparian, Zhengping Zhuang et al. · Oncogene · 2009 · 116 citations

Molecular Pharmacology, 9-Aminoacridine-based Anticancer Drugs, Drug Targeting +11

Effects of IKK inhibitor PS1145 on NF-κB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells

Alexander Yemelyanov, A. V. Gasparian, Paul F. Lindholm et al. · Oncogene · 2005 · 111 citations

Medicine, Pharmacology, Cancer Cell Biology +10

Allelic imbalance and instability of microsatellite loci on chromosome 1p in human non-small-cell lung cancer

A. V. Gasparian, MS-O Belialova, NA Pirogova et al. · British Journal of Cancer · 1998 · 25 citations · Full text

Allelic Variant, Somatic Variant, Tumor Heterogeneity +11

Depletion of COPI in cancer cells: the role of reactive oxygen species in the induction of lipid accumulation, noncanonical lipophagy and apoptosis

A. V. Gasparian, Marina Aksenova, David J. Oliver et al. · Molecular Biology of the Cell · 2022 · 14 citations · Full text

Regulation of matrix metalloproteinase-9 transcription in squamous cell carcinoma of uterine cervix: the role of human papillomavirus gene E2 expression and activation of transcription factor NF-κB

A. V. Gasparian, M. D. Fedorova, F. L. Kisseljov · Biochemistry (Moscow) · 2007 · 10 citations